# OnCo record danatlas-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/danatlas-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "danatlas-pharmaceuticals" ;
  schema:name "Danatlas Pharmaceuticals"@en ;
  schema:alternateName "Danatlas Pharmaceuticals Co., Ltd"@en, "浙江丹擎药业科技有限公司"@en, "Beijing Danatlas"@en ;
  schema:description "Danatlas Pharmaceuticals is a Chinese company developing tablets that exploit weaknesses in how some cancer cells repair their DNA. Its lead drug, DAT-2645, is aimed at cancers with BRCA mutations, including ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/danatlas-pharmaceuticals/>, <https://www.danatlas.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.danatlas.com/>, <https://clinicaltrials.gov/study/NCT06614751>, <https://clinicaltrials.gov/study/NCT06998173>, <https://clinicaltrials.gov/study/NCT07652073> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/> ;
  onco:targets <https://onco.cc/targets/brca/> .